BioAdvance News

Everest Medicines Announces Top-line Results from Phase 1 Clinical Trial of Taniborbactam in Combination with Cefepime in China

By WebmasterSeptember 14, 2020November 1st, 2024No Comments

Everest Medicines Announces Top-line Results from Phase 1 Clinical Trial of Taniborbactam in Combination with Cefepime in China

Previous PostMelior Pharmaceuticals Awarded Grant for Advancing Pulmonary Therapeutic in COVID-19 Phase 2 Clinical Trial
Next PostWellsheet Deployed by RWJBarnabas Health Improves Clinical Workflow and Improves Patient Care